Related content

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers

By  

The Journal Of Pathology: Clinical Research, Vol. 1, Iss. 1, 2015-02 ,pp. : 33-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRCA1 Mutations in Familial Ovarian Cancer

By Lallas T.A.   Buekers T.E.   Buller R.E.  

Molecular Genetics and Metabolism, Vol. 67, Iss. 4, 1999-08 ,pp. : 357-363

Academic Press

Access to resources Recommend Favorite

Erratum to: Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours

By Milner Roy   Wombwell Helen   Eckersley Sonia   Barnes Donna   Warwicker Juli   Dorp Erica   Rowlinson Rachel   Dearden Simon   Hughes Glen   Harbron Chris   Wellings Bob   Hodgson Darren   Womack Chris   Gray Neil   Lau Alan   O’Connor Mark   Marsden Catherine   Kvist Alexander  

Virchows Archiv, Vol. 462, Iss. 5, 2013-05 ,pp. : 601-601

Springer Publishing Company

Access to resources Recommend Favorite

Association of EGFR mutations with low BRCA1 gene expression in non-small cell lung cancer

By Li   Xie   Lai  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 195-199

Spandidos Publications

Access to resources Recommend Favorite

Regulation of MCP-3 and BRCA2 mRNA Expression Levels by 1 Integrins

By Moro L.   Fornaro M.   Steger C.A.   Languino L.R.  

Experimental and Molecular Pathology, Vol. 70, Iss. 3, 2001-06 ,pp. : 239-247

Elsevier

Access to resources Recommend Favorite